Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|May 19, 2025
Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's diseaseClíona Farrell, Yazead Buhidma, Paige Mumford, et al.
Nature Communications|July 4, 2013
Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healingMark A Evans, Nicola Smart, Karina N Dubé, et al.
Analytical Chemistry|February 15, 2017
Multiplex High-Throughput Targeted Proteomic Assay To Identify Induced Pluripotent Stem CellsAnna Baud, Frank Wessely, Francesca Mazzacuva, et al.
Frontiers in Molecular Biosciences|April 27, 2026
Sex-based antibody subclass maturation drives direct enzymatic inhibition in fabry disease patients receiving enzyme replacement therapyTomas Baldwin, Hibba Kurdi, Ivan Doykov, et al.
The Journal of Investigative Dermatology|December 27, 2016
Autosomal Recessive Keratoderma-Ichthyosis-Deafness (ARKID) Syndrome Is Caused by VPS33B Mutations Affecting Rab Protein Interaction and Collagen ModificationRobert Gruber, Clare Rogerson, Christian Windpassinger, et al.
Circulation. Genomic and Precision Medicine|December 19, 2018
Proteomic Analysis of the Myocardium in Hypertrophic Obstructive CardiomyopathyCaroline J Coats, Wendy E Heywood, Alex Virasami, et al.
Analytical Chemistry|November 6, 2015
Proteomic Discovery and Development of a Multiplexed Targeted MRM-LC-MS/MS Assay for Urine Biomarkers of Extracellular Matrix Disruption in Mucopolysaccharidoses I, II, and VIWendy E Heywood, Stephane Camuzeaux, Ivan Doykov, et al.
Brain, Behavior, and Immunity|December 13, 2025
Resistant starch improves Parkinson's disease symptoms through restructuring of the gut microbiome and modulating inflammationViacheslav A Petrov, Sebastian Schade, Cedric C Laczny, et al.
Scientific Reports|June 22, 2016
The embryological basis of subclinical hypertrophic cardiomyopathyGabriella Captur, Carolyn Y Ho, Saskia Schlossarek, et al.
JAMA Neurology|January 14, 2020
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled TrialStephen Mullin, Laura Smith, Katherine Lee, et al.
Pageof 13